Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Physiology - Gastrointestinal and Liver Physiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPGI.2000.278.1.G64PMID 10644563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

  1998cited by this paper
• International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

  1998cited by this paper
• Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.

  1998cited by this paper
• The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.

  1997cited by this paper
• Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.

  1997cited by this paper
• Development of high affinity selective VIP1 receptor agonists.

  1997cited by this paper
• Tissue Specific Expression of Different Human ReceptorTypes for Pituitary Adenylate Cyclase Activating Polypeptideand Vasoactive Intestinal Polypeptide: Implications fortheir Role in Human Physiology

  1996cited by this paper
• Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor.

  1995cited by this paper
• Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.

  1994cited by this paper
• Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.

  1994cited by this paper
• Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.

  1994influential reference
• A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists.

  1994cited by this paper
• Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.

  1994cited by this paper
• Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.

  1994cited by this paper
• Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.

  1994cited by this paper
• The Pancreas : biology, pathobiology, and disease

  1993cited by this paper
• The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

  1993influential reference
• Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.

  1993cited by this paper
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

  1992influential reference
• Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells

  1991cited by this paper
• Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.

  1989influential reference
• Solid phase synthesis of peptides containing the CH2NH peptide bond isostere.

  1987cited by this paper
• Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini.

  1987influential reference
• Receptors involved in helodermin action on rat pancreatic acini.

  1986influential reference
• The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.

  1986cited by this paper
• Receptors for secretagogues on pancreatic acinar cells.

  1984cited by this paper
• Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini.

  1984influential reference
• Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini.

  1983cited by this paper
• Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas.

  1982cited by this paper
• Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium.

  1982cited by this paper
• Actions of a newly isolated intestinal peptide PHI on pancreatic acini.

  1981cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980influential reference
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980influential reference
• Receptor for secretagogues on pancreatic acinar cells.

  1980cited by this paper
• Interaction of secretin5-27 and its analogues with hormone receptors on pancreatic acini.

  1979influential reference
• Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas.

  1978cited by this paper
• Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate.

  1976cited by this paper
• Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.

  1976cited by this paper

• VIP Receptors

  2021cites this paper
• Vasoactive Intestinal Polypeptide or VIP

  2020influential citation
• Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

  2019cites this paper
• Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na+,K+-ATPase in pancreatic acinar cells.

  2019cites this paper
• A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.

  2015cites this paper
• Adenylyl Cyclases

  2014influential citation
• Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.

  2011cites this paper
• Vasoactive Intestinal Peptide (VIP) and VIP Receptors-Elucidation of Structure and Function for Therapeutic Applications

  2011cites this paper
• Gastrointestinal growth factors and hormones have divergent effects on Akt activation.

  2009cites this paper
• Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.

  2008cites this paper
• Tumor M 2-Pyruvate Kinase and Pancreatic Cancer

  2008cites this paper
• Metastatic Tumors of the Pancreas

  2008cites this paper
• Receptors for VIP and PACAP in guinea pig cerebral cortex

  2007cites this paper
• Vectorial Bicarbonate Transport by Capan-1 Cells: a Model for Human Pancreatic Ductal Secretion

  2006cites this paper
• Differential Activation of Adenylate Cyclase by Secretin and VIP Receptors in the Calf Pancreas

  2005influential citation
• VIP Immunoreacty in Human

  2005cites this paper
• Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors

  2005cites this paper
• VIP Immunoreacty in Human Aqueous Humor

  2005cites this paper
• VIP Attenuation of the Severity of Experimental Pancreatitis Is Due to VPAC1 Receptor-Mediated Inhibition of Cytokine Production

  2005cites this paper
• VIP Immunoreactivity in Human Aqueous Humor

  2005cites this paper
• Distribution of the VPAC2 receptor in peripheral tissues of the mouse.

  2004cites this paper
• Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3

  2004cites this paper
• CHAPTER 336 – Development and Regulatory Signaling in the Pancreas

  2003cites this paper
• Effects of Pituitary Adenylate Cyclase—Activating Polypeptide on Facial Nerve Recovery in the Guinea Pig

  2003cites this paper
• Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors

  2002influential citation
• VIP Stimulation of cAMP Production in Corneal Endothelial Cells in Tissue and Organ Cultures

  2002cites this paper
• Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.

  2002influential citation
• (N-stearyl, norleucine17) VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist

  2002cites this paper
• Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3*

  2001cites this paper
• Regulation of slowly activating potassium current (IKs) by secretin in rat pancreatic acinar cells

  2001cites this paper
• GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity.

  2001cites this paper